Trading Summary - April 1. A more than satisfactory

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
187
Trading Summary - April 1.

A more than satisfactory status quo day with upward movement and all trades within the 25% percentile under .0050 of the .02+ anticipated in 2022.

With a PR today on the excellent 2021 results which close followers already knew from the Annual Report, more new interest and former bid sitters committed to buying on the ask at .0011 + .0012 (rather than the mostly .0010 and .0011 yesterday).

At the open, MM OTCX signalled by moving up to .0012 and in early trading all original .0011 and .0012 were bought out rapidly and the .0013s were up. However, amateurs had stacked too much on the ask at once (30M) and so many low level flippers not committed to the stock long term took profits on walked down asks at .0011.

Bid at .0009 peaked at 80M+ with no significant fills and bids at .0010 were rarely filled.

By the close, .0012s were going again and after day trades were cancelled only 5.7M remained.

See earlier contemporaneous posts for significant moves / trades.

As has been mentioned for months in the DD and daily Trading Summaries, it makes little difference to the OTC market top long-term continuous traders of $SFLM where they buy in the .0011 > .0050 range as they are expecting .02+ eventually - although of course any low level flipping profits will be different.

There was an 11.26M cross trade at 14:42:40 with no effect on the bid .

Overall, 132M shares were traded today. When we get the next share structure update on / around April 11, I expect to see that the volume for March 31 + April 1 will make any increase in the last 30 days insignficant in the grand scheme.

The Share Structure was updated as at March 11 with only 281.25M added to the Unrestricted Outstanding Shares count. This was not significant as 821M shares were traded over the 30-day period concerned - including 346M in just 5 of them. More importantly, it looks like at least 4 x $50K Public Offering investments were made and the increased cash flow enabled increased inventory to be acquired each week which resulted in around $400K more in revenue over the period ($256K + $319K + $298K + $362K in Weeks 7-10 compared to a norm of $200K > $230K previously) and $355K in Week 11, $283K in Week 12 and at least $324K in Week 13. The increased revenue meant that the 2022 estimated total went up to $14.5M+ - thereby the small share increase has little effect on the correct price for market cap (see detail calculations in the updated DD).

We can expect asks in the .0015 to .0020 range to get back to the more normal 5M > 500K and then more usually 1M > 200K after that all the way to .01+.

None of the asks are of any significance to hinder a quick break above .0020 towards the .01 > .02 range needed for OTCQB uplisting - and as appropriate to its $14.5M+ revenue estimate currently (even before diversification of revenue streams).

We still need to see significant buys across several asks at the open that are crucial to getting the breakout to the .01 > .02+ range started.

The facts about the Public Offering and the Share Structure are as follows (as already in the master DD updated weekly):

- 2 Billion shares have not been issued - 2 Billion shares have been offered for purchase in initial blocks of $50K / 62.5M or follow on blocks of $10K / 12.5M - as stated in the DD.

As at the latest update dated March 11, only 7 x such purchases could have been made - also in the DD.

- The previous Public Offering of 2.2 Billion only had 352.5M bought throughout 2021 and all that was most probably traded on the runs to .02.

- The last reverse split of the predecessor company $SKDI was on June 3, 2019 and is irrelevant.

- The CEO has already stated that there is no reason for a reverse split - and there clearly isn't any need for one [source: PR October 9, 2020].

- Share Structure updated March 11, 2022 and analysis here:

https://investorshangout.com/post/view?id=6361054

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy is currently .0746.

Remember that the price difference between .0012 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .0746 - apart from the additional partial profits taken on the way to the long-term target.

Every 1M bought at .0015 is worth $10.5K profit at .0120.

Every 1M bought at .0020 is worth a $10K profit at .0120 or $18K profit at .02.

Latest DD - updated March 26 - here:

https://investorshangout.com/post/view?id=6370708

$SFLM was the #1 Top Profit Pick and #1 Top Banked Profit stock of 2021 and 2020 on my Watch List.

It is also my #1 Top Profit Pick for the whole of 2022.

Major catalysts ahead in 2022 are:

- Continued excellent revenue growth from the core Jewelry Division.

- Updates on the Metaverse Division.

- Updates on the NFT Division.

- Update on Bitcoin activities (new additioned announced March 31).

- Acquisitions of other collectibles companies - some already in discussions.

- 2022 Q1 Report filing.

- OTCQB uplisting.

13th CEO Video here:

https://vimeo.com/673267050

14th CEO Video here:

https://vimeo.com/675954496

Key Points from 2021 Annual Report showing the excellent progress made:

https://investorshangout.com/post/view?id=6373719

Watch out for the next PR which we can expect to be on one of more of the following:

- Week 13 sales.

- March 2022 revenue - expected to be an all-time record.

- Further progress of getting the Metaverse Division earning.

The company Tweeted March 30 that it expected this weeks' revenue to be over $300K . With a higher than normal inventory for sale this week and bidding wars taking place, this transpired to be the case.

March 2022 was indeed therefore over $1.5M.


Weeks 13 revenue is at least $324K - watch out for the official company update later today - close followed by my update of 2022 Total Revenue so far.

As usual, I'll be updating the DD over the weekend.

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Caitlyn Brazill Takes Helm at Per Scholas: CEO Transition

Updated Category News Views 2

Caitlyn Brazill named CEO, marking a leadership shift Call this one a big baton pass in the world of workforce development. Caitlyn Brazill is stepping into the role of CEO and President at Per Scholas, effective January 1, 2027. She'll be filling the rather large shoes of Plinio Ayala, the man who's been steering the ship since its days in the Bronx, growing it into a...

Continue Reading
Armor Health Strengthens Corrections Care with New Leader

Updated Category News Views 1

Fresh Blood in Correctional Healthcare Talk about stepping up where it counts! Armor Health is shaking things up, bringing in Jill Bromley as their new Regional Behavioral Health Director. The name might not ring any bells for the average Joe, but in the world of correctional healthcare, it’s like they've just upgraded from a sedan to a sports car. Armor’s game here...

Continue Reading
ODL’s Impact Door System Wins 2026 Editors' Pick

Updated Category News Views 1

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

Continue Reading
CellFiber Expands to Philly: Boosting US Biotech Scene

Updated Category News Views 3

CellFiber's Leap into 'Cellicon Valley' Folks, when the biotech winds start blowing, you better have your sails up. CellFiber Co., Ltd., a Tokyo-based innovator, has landed itself a comfy spot in the City of Brotherly Love. We're talking Philadelphia, folks, or, as it's dubbed in certain circles, 'Cellicon Valley.' Now if that's not a name that screams biotech pedigree, I...

Continue Reading
Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 2

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading
AI Visibility: A Game Changer for SEO in 2027?

Updated Category News Views 2

AI Changes the SEO Game Rank Math, the brains behind a trusty WordPress SEO plugin, has thrown a bold prediction at us: AI visibility is set to become a standard SEO metric next year. Gurugram, India, saw this gem of an announcement on October 9, 2026. So, what's ticking here? Consumers, more than ever, are resting on AI-generated answers to make decisions. It's like...

Continue Reading
Moore, Schulman & Moore Attorneys Earn Top Honors Again

Updated Category News Views 2

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Continue Reading
Strategic Move: Chimney Collective Teams with Four Winds

Updated Category News Views 4

A Partnership Fueled by Legacy and Growth In the world of brick, mortar, and flue, a big play just unfolded. Chimney Collective, flexing its investment muscle, has hitched its wagon to Four Winds Chimney, a company that's carved out quite a niche in New York's chimney scene. We're not talking about a corporate takeover here; this is about putting money where growth and...

Continue Reading
India's Women Apparel Market Grows Amid Innovation

Updated Category News Views 0

India's Women Apparel Market on the Rise The winds of fashion change are sweeping through India, and the women's apparel market is at the heart of this sartorial hurricane. Set to explode from USD 28,786.82 million in 2024 to USD 45,491.96 million by 2032, this market is turning heads with a compound annual growth rate (CAGR) of 5.21%. What's stirring this pot, you ask?...

Continue Reading
Toyland 2026: Blain's 'Open The Magic' Event Marks 69 Years

Updated Category News Views 0

There's something about nostalgia that hooks you right in the gut, like remembering those jittery walks through Blain's Farm & Fleet's Toyland aisles. If there's one thing these folks know, it's how to spark holiday cheer deep in the Midwest bones. Here we are, just before the dust settles on another year, and Blain's is rolling out its 69th Toyland party—a cherished...

Continue Reading

Top 5 Most Recently Viewed Articles

Welltower's Remarkable Growth: $100 Investment Today Worth $1571

Updated Category News Views 214

Welltower's Growth Over 15 Years Welltower (NYSE: WELL), a leader in the real estate investment trust (REIT) sector, has shown impressive growth over the past 15 years, consistently outperforming the market. With an annualized return averaging 20.07%, Welltower has effectively generated a remarkable 7.9% more than broader market indices. As of now, Welltower boasts a...

Continue Reading
Cognizant and WRITER Team Up for AI-Driven Industry Change

Updated Category News Views 138

Cognizant Partners with WRITER for AI Innovations Cognizant (NASDAQ: CTSH), a major player in the technology and consulting sector, has recently announced an exciting partnership with WRITER. This collaboration aims to leverage artificial intelligence (AI) to accelerate transformation processes across different industries. Both companies are committed to driving...

Continue Reading
Biocodex Unveils Innovative Oral Suspension for Dravet Syndrome

Updated Category News Views 176

Revolutionizing Treatment for Dravet Syndrome In a significant development within the realm of pediatric epilepsy, Biocodex announces an exciting innovation involving DIACOMIT, otherwise known as stiripentol. This newly formulated oral suspension aims to refine treatment for young children suffering from Dravet syndrome, a particularly severe form of epilepsy that begins...

Continue Reading
Zinzino AB Reports Robust Growth in First Quarter Performance

Updated Category News Views 234

Zinzino AB Highlights Impressive Growth in Q1 2025 In an impressive testament to its operational strength, Zinzino AB has announced notable revenue growth for the first quarter of 2025. Rising to SEK 723.7 million from SEK 454.5 million indicates a significant growth rate of 59% compared to the same period last year. This remarkable surge reflects Zinzino's robust market...

Continue Reading
Roche's New CE Mark Enhances Antimicrobial Resistance Management

Updated Category News Views 118

Roche Enhances Diagnostic Capabilities with CE Mark Approval Roche has achieved a remarkable milestone by securing CE Mark approval for its mass spectrometry reagent pack dedicated to antibiotics drug monitoring. This significant development positions Roche’s automated mass spectrometry platform as the industry leader, boasting an extensive in-vitro diagnostic menu that...

Continue Reading